BACKGROUND Hydroxyurea(HU)is a non-alkylating antineoplastic agent that is active in the Sphase of the cell cycle and inhibits the enzyme ribonucleoside reducta
Chronic kidney disease and its worsening are recurring conditions in chronic heart failure(CHF)which are independently associated with poor patient outcome.The